How many studies have been published on each of the three cancer biomarkers?

Each of the three cancer biomarkers in OncuraKit has been individually studied in over 700 peer-reviewed publications: miR-21-5p has been featured in well over 1,000 cancer-related studies — it is the most studied oncogenic miRNA in the literature. miR-375-3p has approximately 700+ focused studies with a strong concentration in prostate, gastric, and pancreatic cancer research. miR-141-3p has 700+ studies, with particularly strong representation in prostate and colorectal cancer. Collectively, these three markers have been validated in more than 70,000 patient and control samples across diverse populations, cancer types, and research centers worldwide. This is not early-stage experimental science — it is among the most deeply validated molecular oncology evidence available.